Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
LivaNova PLC

LivaNova PLC (LIVN) Stock Overview

Explore LivaNova PLC’s financial performance, market position, analyst ratings, and future outlook.

LIVN●NASDAQ
HealthcareMedical - Devices
$92.61
$2.62(2.91%)
U.S. Market opens in 15h 51m

LivaNova PLC (LIVN)

Meyka AI Score

Z

Key Financials

Market Cap5.1B
P/E Ratio25.30
EPS (TTM)$4.21
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$103.02
3 Months$90.51
1 Year Target$87.43

LIVN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of LivaNova PLC (NASDAQ: LIVN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, LivaNova PLC's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of LIVN on the NASDAQ shows an RSI of 70.23, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $87.43 for the NASDAQ listing.

Key metrics behind LivaNova PLC's NASDAQ-traded stock include a P/E ratio of 25.30 and a market capitalization of 5.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of LIVN on the NASDAQ.

Price Performance (NASDAQ: LIVN)

1-Day Change
2.91%
5-Day Change
3.27%
1-Month Change
21.23%
3-Month Change
21.50%
6-Month Change
28.88%
Year-to-Date (YTD) Change
50.51%
1-Year Change
82.02%
3-Year Change
101.11%
5-Year Change
-0.08%
All-Time (Max) Change
32.43%

Contact Information

https://www.livanova.com
44 20 3325 0660
5220 Valiant Court, Gloucester, GL, GL3 4FE

Company Facts

33,000 Employees
IPO DateOct 19, 2015
CountryGB
Actively Trading

Frequently Asked Questions